Bacterial resistance to CRISPR-Cas antimicrobials DOI Creative Commons
Ruben Vazquez-Uribe,

Christin Rathmer,

Leonie J. Jahn

et al.

Scientific Reports, Journal Year: 2021, Volume and Issue: 11(1)

Published: Aug. 26, 2021

Abstract In the age of antibiotic resistance and precise microbiome engineering, CRISPR-Cas antimicrobials promise to have a substantial impact on way we treat diseases in future. However, efficacy these their mechanisms remain be elucidated. We systematically investigated how target E. coli strain can escape killing by episomally-encoded CRISPR-Cas9 antimicrobials. Using Cas9 from Streptococcus pyogenes (SpCas9) studied efficiency mutation rate towards elucidated underlying genetic alterations. find that is not correlated with number cutting sites or type target. While targets did significantly affect killing, it reduce emergence chromosomal mutations conferring resistance. The most frequent was plasmid-encoded SpCas9 inactivated bacterial genome rearrangements involving translocation mobile elements such as insertion elements. This mechanism overcome re-introduction an intact copy SpCas9. work presented here provides guide design strategies improve activity

Language: Английский

The role of ROS in tumour development and progression DOI
Eric C. Cheung, Karen H. Vousden

Nature reviews. Cancer, Journal Year: 2022, Volume and Issue: 22(5), P. 280 - 297

Published: Jan. 31, 2022

Language: Английский

Citations

987

The updated landscape of tumor microenvironment and drug repurposing DOI Creative Commons

Ming-Zhu Jin,

Weilin Jin

Signal Transduction and Targeted Therapy, Journal Year: 2020, Volume and Issue: 5(1)

Published: Aug. 25, 2020

Abstract Accumulating evidence shows that cellular and acellular components in tumor microenvironment (TME) can reprogram initiation, growth, invasion, metastasis, response to therapies. Cancer research treatment have switched from a cancer-centric model TME-centric one, considering the increasing significance of TME cancer biology. Nonetheless, clinical efficacy therapeutic strategies targeting TME, especially specific cells or pathways remains unsatisfactory. Classifying chemopathological characteristics crosstalk among one another greatly benefit further studies exploring effective treating methods. Herein, we present an updated image with emphasis on hypoxic niche, immune microenvironment, metabolism acidic innervated mechanical microenvironment. We then summarize conventional drugs including aspirin, celecoxib, β-adrenergic antagonist, metformin, statin new antitumor application. These are considered as viable candidates for combination therapy due their activity extensive use practice. also provide our outlook directions potential applications theory. This review depicts comprehensive vivid landscape biology treatment.

Language: Английский

Citations

893

Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer DOI Creative Commons
Aikun Fu,

Bingqing Yao,

Tingting Dong

et al.

Cell, Journal Year: 2022, Volume and Issue: 185(8), P. 1356 - 1372.e26

Published: April 1, 2022

Language: Английский

Citations

584

Hallmarks of Health DOI Creative Commons
Carlos López‐Otín, Guido Kroemer

Cell, Journal Year: 2020, Volume and Issue: 184(1), P. 33 - 63

Published: Dec. 18, 2020

Language: Английский

Citations

377

Microbiome and cancer DOI Creative Commons
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman

et al.

Cancer Cell, Journal Year: 2021, Volume and Issue: 39(10), P. 1317 - 1341

Published: Sept. 9, 2021

Language: Английский

Citations

362

Cancer and the Microbiome—Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy DOI
Vyara Matson,

Carolina Soto Chervin,

Thomas F. Gajewski

et al.

Gastroenterology, Journal Year: 2020, Volume and Issue: 160(2), P. 600 - 613

Published: Nov. 28, 2020

Language: Английский

Citations

280

Chemically and Biologically Engineered Bacteria‐Based Delivery Systems for Emerging Diagnosis and Advanced Therapy DOI
Zhaoting Li, Yixin Wang, Jun Liu

et al.

Advanced Materials, Journal Year: 2021, Volume and Issue: 33(38)

Published: Aug. 4, 2021

Abstract Bacteria are one of the main groups organisms, which dynamically and closely participate in human health disease development. With integration chemical biotechnology, bacteria have been utilized as an emerging delivery system for various biomedical applications. Given unique features such their intrinsic biocompatibility motility, bacteria‐based systems drawn wide interest diagnosis treatment diseases, including cancer, infectious kidney failure, hyperammonemia. Notably, at interface biotechnology bacteria, many research opportunities initiated, opening a promising frontier application. Herein, current synergy design principles systems, microbial modulation, clinical translation reviewed, with special focus on advances therapy.

Language: Английский

Citations

175

Antigen presentation in cancer — mechanisms and clinical implications for immunotherapy DOI
Kailin Yang, Ahmed Halima, Timothy A. Chan

et al.

Nature Reviews Clinical Oncology, Journal Year: 2023, Volume and Issue: 20(9), P. 604 - 623

Published: June 16, 2023

Language: Английский

Citations

115

Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling DOI
Barath Udayasuryan, Raffae N. Ahmad, Tam T. D. Nguyen

et al.

Science Signaling, Journal Year: 2022, Volume and Issue: 15(756)

Published: Oct. 18, 2022

The tumor microbiome is increasingly implicated in cancer progression and resistance to chemotherapy. In pancreatic ductal adenocarcinoma (PDAC), high intratumoral loads of Fusobacterium nucleatum correlate with shorter survival patients. Here, we investigated the potential mechanisms underlying this association. We found that F. infection induced both normal epithelial cells PDAC secrete increased amounts cytokines GM-CSF, CXCL1, IL-8, MIP-3α. These proliferation, migration, invasive cell motility infected noninfected but not noncancerous cells, suggesting autocrine paracrine signaling cells. This phenomenon occurred response regardless strain absence immune other stromal Blocking GM-CSF markedly limited proliferative gains after infection. Thus, pancreas elicits cytokine secretion from cancerous promotes phenotypes associated progression. findings support importance exploring host-microbe interactions guide future therapeutic interventions.

Language: Английский

Citations

76

Cancer metastasis: Molecular mechanisms and clinical perspectives DOI
Sameer Ullah Khan,

Kaneez Fatima,

Fayaz Malik

et al.

Pharmacology & Therapeutics, Journal Year: 2023, Volume and Issue: 250, P. 108522 - 108522

Published: Sept. 1, 2023

Language: Английский

Citations

61